Stockscreener 앱 받기
9.07
3.30%
-0.31
시장 영업 전:
9.65
0.58
+6.39%
전일 마감가:
$9.38
열려 있는:
$9.26
하루 거래량:
790.73K
Relative Volume:
0.99
시가총액:
$269.05M
수익:
$36.97M
순이익/손실:
$-25.54M
주가수익비율:
-10.05
EPS:
-0.9022
순현금흐름:
$-24.45M
1주 성능:
-0.33%
1개월 성능:
-9.30%
6개월 성능:
-65.63%
1년 성능:
-17.17%
1일 변동 폭
$8.90
$9.28
1주일 범위
$8.6838
$9.5299
52주 변동 폭
$8.595
$30.10
Clearpoint Neuro Inc Stock (CLPT) Company Profile
명칭
Clearpoint Neuro Inc
전화
(949) 900-6833
주소
120 S. SIERRA AVENUE, SOLANA BEACH, CA
Compare CLPT vs ABT, SYK, MDT, BSX, EW
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
CLPT
Clearpoint Neuro Inc
|
9.07 | 269.05M | 36.97M | -25.54M | -24.45M | -0.9022 |
ABT
Abbott Laboratories
|
101.83 | 176.95B | 44.33B | 6.50B | 7.40B | 3.717 |
SYK
Stryker Corp
|
332.07 | 127.18B | 25.12B | 3.25B | 4.28B | 8.3984 |
MDT
Medtronic Plc
|
86.42 | 110.95B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
61.86 | 91.93B | 20.08B | 2.89B | 3.66B | 1.9391 |
EW
Edwards Lifesciences Corp
|
80.84 | 46.61B | 6.07B | 1.06B | 1.34B | 1.8063 |
Clearpoint Neuro Inc Stock (CLPT) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-07-25 | 재개 | B. Riley Securities | Buy |
| 2023-10-24 | 개시 | Stifel | Buy |
| 2023-02-16 | 재개 | B. Riley Securities | Buy |
| 2022-04-05 | 재개 | B. Riley Securities | Buy |
| 2021-03-18 | 개시 | Lake Street | Buy |
| 2020-07-17 | 개시 | B. Riley FBR | Buy |
모두보기
Clearpoint Neuro Inc 주식(CLPT)의 최신 뉴스
Update Report: Can ClearPoint Neuro Inc be the next market leaderQuarterly Profit Summary & Free Real-Time Market Sentiment Alerts - baoquankhu1.vn
ClearPoint Neuro (CLPT) price target decreased by 10.71% to 25.50 - MSN
ClearPoint Neuro, Inc. (CLPT) stock price, news, quote and history - Yahoo Finance UK
Why The ClearPoint Neuro (CLPT) Investment Story Is Shifting On Regulatory And Partnership Risks - Yahoo Finance
Value Recap: What are the future prospects of ClearPoint Neuro IncShort Setup & AI Enhanced Trading Alerts - baoquankhu1.vn
CLPT Technical Analysis & Stock Price Forecast - Intellectia AI
ClearPoint Neuro (CLPT) director awarded 755 shares as stock compensation - Stock Titan
ClearPoint Neuro (CLPT) director receives 1,270-share stock grant as fees - stocktitan.net
ClearPoint Neuro (CLPT) director granted 442-share stock fee award - stocktitan.net
CLPT Stock Price, Quote & Chart | CLEARPOINT NEURO INC (NASDAQ:CLPT) - ChartMill
Clearpoint Neuro, Valneva, Rocket Lab and other big stocks moving lower in Wednesday's pre-market session - msn.com
Will ClearPoint Neuro Inc benefit from current market trends2026 Recap & Accurate Entry and Exit Point Alerts - baoquankhu1.vn
Short Interest in ClearPoint Neuro Surges 29% in March - National Today
ClearPoint Neuro, Inc. (NASDAQ:CLPT) Short Interest Up 29.0% in March - MarketBeat
Can ClearPoint Neuro Inc be the next market leaderEarnings Recap Report & Growth Focused Stock Reports - baoquankhu1.vn
What are the future prospects of ClearPoint Neuro Inc2026 Final Week & Stock Market Timing Techniques - baoquankhu1.vn
Vanguard amendment shows 0% stake in ClearPoint Neuro (CLPT) after realignment - Stock Titan
ClearPoint Neuro (CLPT) moves 8.1% higher: Will this strength last? - MSN
Why The ClearPoint Neuro (CLPT) Story Is Shifting After New Partner And FDA Updates - Yahoo Finance
ClearPoint Neuro plunges as FY26 guidance falls below analysts' estimates - MSN
Trading Systems Reacting to (CLPT) Volatility - Stock Traders Daily
ClearPoint Neuro (CLPT) CEO exercises options and holds all shares - Stock Titan
Fundamentals Check: Will ClearPoint Neuro Inc benefit from current market trendsInsider Selling & Weekly Momentum Stock Picks - baoquankhu1.vn
Analysts Are Bullish on Top Healthcare Stocks: ClearPoint Neuro (CLPT), Xtant Medical Holdings (XTNT) - The Globe and Mail
ClearPoint Neuro, Inc. (NASDAQ:CLPT) Q4 2025 Earnings Call Transcript - Insider Monkey
Clearpoint Neuro’s IRRAS Acquisition: Integration Risks Threaten Promised Scale and Synergies - TipRanks
ClearPoint Neuro FY 2025 Revenue Growth Reinforces Bullish Narratives Despite Persistent EPS Losses - simplywall.st
Intuitive Surgical Stock: Buy, Sell, or Hold? - AOL.com
ClearPoint Neuro Reports Record 2025 Results, Expands Growth Outlook - The Globe and Mail
ClearPoint Neuro Q4 Earnings Call Highlights - MarketBeat
ClearPoint Neuro (NASDAQ:CLPT) Given New $20.00 Price Target at B. Riley Financial - MarketBeat
ClearPoint Neuro (CLPT) Sees Raised Price Target from B. Riley S - GuruFocus
Clearpoint Neuro, Valneva, Rocket Lab And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session - Benzinga
B. Riley Raises Price Target on ClearPoint Neuro to $20 From $18, Keeps Buy Rating - MarketScreener
ClearPoint Neuro, Inc. Q4 2025 earnings preview - MSN
ClearPoint Neuro (CLPT) Surpasses Q4 Revenue Expectations with S - GuruFocus
Clearpoint Neuro earnings missed by $0.08, revenue topped estimates - Investing.com Canada
ClearPoint Neuro, Inc. (CLPT) Q4 2025 Earnings Call Transcript Summary - 富途牛牛
CLPT Revenue Rises, Losses Widen Amid Cautious 2026 Outlook - Bitget
ClearPoint Neuro, Inc. (CLPT) reports Q4 loss, tops revenue estimates - msn.com
ClearPoint Neuro, Inc. Q4 2025 Earnings Call Summary - Yahoo Finance
ClearPoint Neuro outlines $52M–$56M 2026 revenue target as company advances growth strategy and integrates IRRAS acquisition - MSN
Clearpoint Neuro Inc (CLPT) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.44%
0.34%
자본화:
|
볼륨(24시간):